Dr. Magi-Galluzzi is Professor and Chair of the Department of Pathology at the University of Alabama at Birmingham, where she currently holds the Robert and Ruth Anderson Endowed Chair in Pathology in the Heersink School of Medicine.

She received her MD at the University of Ancona, School of Medicine, Italy and her PhD in Oncologic Human Pathology at the University of Verona, Italy. She completed her residency in Anatomic and Clinical Pathology at Rush University Medical Center in Chicago (1997-1999) and Brigham & Women’s Hospital, Harvard Medical School in Boston (1999-2001), followed by a fellowship in Urologic Pathology at the Johns Hopkins University in Baltimore (2001-2003). She was on staff at the Cleveland Clinic from 2003 to 2018 and Director of Genitourinary pathology from 2004 to 2018. In October 2018, Dr. Magi-Galluzzi joined the Department of Pathology at the University of Alabama at Birmingham (UAB) as Division Director of Anatomic Pathology. On March 4, 2024, Dr. Magi-Galluzzi was appointed Chair of the UAB Department of Pathology.

Her clinical expertise is in the pathological diagnosis of genitourinary diseases, including prostate, bladder, testicular, adrenal and kidney malignancies. Her research interest focuses on prostate carcinogenesis and in the discovery and validation of tumor markers and genomic tests of value in furthering the goals of successful treatment and understanding of the pathogenesis of genitourinary disease. She is the author of numerous (~280) peer-reviewed publications, invited reviews and book chapters, as well as the editor of four books on genitourinary pathology. She has presented and lectured extensively at national and international meetings and has conducted national and international courses, workshops and slide seminars in urological pathology.

Dr. Nucci is a Professor of Pathology at Harvard Medical School, Vice Chair and Director of the Division Women’s and Perinatal Pathology, and Associate Director of the Pathology Residency Training Program in the Department of Pathology at the Brigham and Women’s Hospital in Boston, MA, USA. She also serves as a Consultant Pathologist for the Dana Farber/Harvard Cancer Center where she is an Associate Member of the Gynecologic Cancer and Sarcoma Programs. Dr. Nucci was born in Newark, NJ. She did her undergraduate training at Haverford College and medical training at the Johns Hopkins University School of Medicine in Baltimore, MD, and completed an AP residency as well as the Women’s and Perinatal Pathology Fellowship at the Brigham and Women’s Hospital. She has been on staff at the Brigham and Women’s Hospital since 1996. She is past president of the New England Society of Pathologists and serves on the editorial boards of The International Journal of Gynecologic Pathology, Human Pathology, and Advances in Anatomic Pathology. She is an active member of the United States and Canadian Academy of Pathology, where she served on the Education Committee (2011-2017), was Chair of the Subcommittee for Unique Live Course Offerings (2012-2017) and is a member of the Board of Directors (2016-). She is also Past-President of the Arthur Purdy Stout Society. She is the co-editor of three widely read major gynecologic pathology textbooks: Diagnostic Gynecologic and Obstetric Pathology edited by Drs. Crum, Nucci and Lee; Gynecologic Pathology. A Volume in the Series Foundations in Diagnostic Pathology edited by Drs. Nucci and Oliva; and Diagnostic Pathology Gynecological edited by Drs. Nucci and Oliva.

Dr. Laura Collins is a Professor of Pathology, the Vice Chair of Oncologic Pathology and Chief of Breast Pathology at Weill Cornell Medicine/New York-Presbyterian and Breast Cancer Research Team Lead in the Meyer Cancer Center at WCM. Dr. Collins earned her medical degree from the Charing Cross and Westminster Medical School in London, UK. She completed a residency in Anatomic and Clinical Pathology and Cytology Fellowship at Beth Israel Deaconess Medical Center, thereafter joining the faculty at BIDMC and rising to the rank of Professor of Pathology at Harvard Medical School. She served as the Vice Chair of Anatomic Pathology at BIDMC for several years and previously as the Program Director of both the Residency and Selective Pathology Fellowship Training Programs.

She has served as a member of the USCAP Education Committee, USCAP Board of Directors, and as the Director of the Interactive Microscopy Courses for USCAP. She is also a Past-President of the Arthur Purdy Stout Society of Surgical Pathologists. Dr. Collins is an internationally renowned breast pathologist. She has published numerous original articles, review articles and book chapters on breast pathology. She has twice been the guest editor for a monograph on Current Concepts in Breast Pathology in the Surgical Pathology Clinics Series. She co-authored the popular pathology textbook entitled “Biopsy Interpretation of the Breast”, now in its fourth edition, is the author of Tumors of The Mammary Gland for the American Registry of Pathology, and she was a contributor to several chapters in the WHO Classification of Tumors of the Breast, 2012, 2019 and 2026.

Her research interests are in breast cancer, and in particular the understanding of precursor lesions and early breast neoplasia. In addition to her work in research, Dr. Collins is a committed educator, giving numerous lectures and post-graduate CME courses around the US and the world to support the ongoing education of pathologists and pathologists-in-training in the diagnosis of breast disease.

Dr. Hornick received a BA from Amherst College and an MD/PhD from the University of Southern California. He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital, where he is the Director of Surgical Pathology and Immunohistochemistry and Chief of Soft Tissue and Bone Pathology. Dr. Hornick is a Professor of Pathology at Harvard Medical School, the Mass General Brigham Endowed Cancer Chair, and a consultant at the Dana-Farber Cancer Institute.

Dr. Hornick is Past-President of the Arthur Purdy Stout Society and previously chaired the USCAP Education Committee, the USCAP Abstract Review Board and Assignment Committee, and the CAP Immunohistochemistry Committee. He served as Co-Director of the Diagnostic Pathology Update course; Coordinator for Soft Tissue Pathology Interactive Microscopy courses; and Moderator of the Bone and Soft Tissue Specialty Conference, the Surgical Pathology Specialty Conference, and platform sessions on Bone and Soft Tissue Pathology and Gastrointestinal Pathology for the USCAP. Dr. Hornick currently serves on the NCCN Bone Cancer Panel and the CAP Personalized Health Care Committee. He was a member of the expert editorial board for the 4th (2013), 5th (2020), and 6th (2025) editions of the WHO Classification of Tumors of Soft Tissue and Bone. Dr. Hornick served on the Anatomic Pathology Test Development and Advisory Committee for the American Board of Pathology, the Soft Tissue Sarcoma Expert Panel for the AJCC, and the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA).

Dr. Hornick is the Editor-in-Chief of the American Journal of Surgical Pathology and the 5th series of the AFIP Atlases of Tumor and Non-tumor Pathology; the Editor of Practical Soft Tissue Pathology and Fletcher’s Diagnostic Histopathology of Tumors; an Associate Editor for Sternberg’s Diagnostic Surgical Pathology, Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, and Advances in Anatomic Pathology; and the Consulting Editor for Surgical Pathology Clinics. He has published over 500 original papers, review articles, and book chapters. Dr. Hornick received the 2012 Arthur Purdy Stout Society Annual Prize, the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society, and the 2023 Mostofi Distinguished Service Award from the USCAP. He has 21-year-old twins and sings and plays keyboards for a rock band (the Tear Downs).

Arie Perry, MD is a Professor of Pathology and Neurological Surgery at the University of California in San Francisco, where he serves as the Director of Neuropathology and the Neuropathology Fellowship program. He received his MD and residency training at UT Southwestern in Dallas, Texas, followed by surgical pathology, neuropathology, and molecular cytogenetics research fellowships at the Mayo Clinic in Rochester, MN, where he worked closely with his mentor, the late Dr. Bernd Scheithauer. His interests have focused mostly on classification, grading, and molecular characterization of both adult and pediatric brain tumors. He has authored over 650 publications and participated as an editor for the WHO 2016 and 2021 (5th ed.) CNS tumor classification updates, as well as an author in 10 of the 5th edition WHO blue books. He has also previously served as a chief editor for Brain Pathology (official journal of the International Society of Neuropathology), the Practical Surgical Neuropathology textbook (2 editions), and Greenfield’s Neuropathology (2 editions). Dr. Perry maintains an active consult service and is a frequently invited lecturer. He also enjoys creative modes of teaching making use of his longstanding passion for music. In this respect, he has been featured in several media stories for using “neuropathology songs” in medical education, including CD recordings and YouTube videos.

Dr. Anil Parwani is a Professor of Pathology and Biomedical Informatics at The Ohio State University. He serves as the Donald A. Senhauser Chair of the Department of Pathology and the Chief of Pathology Services for the Health System. His research is focused on diagnostic and prognostic markers in bladder, prostate, and renal cell carcinoma. Dr. Parwani has expertise in surgical pathology, and pathology informatics including biobanking, whole slide imaging, digital imaging, telepathology, image analysis, artificial intelligence, and lab automation. Dr Parwani has authored over four hundred peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani has served on the board of directors, education committee and abstract committee for USCAP and was the president of digital pathology association. He has also served on several committees including the AI Committee for the CAP. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and Co-editor of the Journal of Pathology Informatics.

Professor Kimberly Allison is the Vice Chair of Education at Stanford Pathology, where she specializes in the practice of breast pathology. She directs a Breast Pathology Fellowship as well as the Breast Pathology
Service at Stanford. Her academic interests are focused on the development of high-quality education and
diagnostic standards and she is active in setting practice guidelines in diagnostic testing relating to
breast cancer, including ASCO/CAP ER/PR and HER2 Testing Guidelines, NCCN Breast Cancer Treatment
Guidelines, CAP Cancer Committee, AJCC staging and the 5th and 6th editions of the WHO Breast Tumours.

Dr. Bishop is the Jane B. and Edwin P. Jenevein, M.D. Chair in Pathology and Professor and Chief of Anatomic Pathology at UT Southwestern Medical Center. Dr. Bishop is an expert in the surgical pathology diagnosis of head and neck and endocrine diseases. He has published more than 250 journal articles, 35 book chapters, and 9 books, and lectured extensively both nationally and internationally. Dr. Bishop was an editor for the most recent WHO Classification of Head and Neck Tumors, and the lead author of the upcoming AFIP Fascicle of Salivary Gland Tumors. He is the editor-in-chief of Seminars in Diagnostic Pathology, an associate editor for Modern Pathology and JAMA Otolaryngology-Head and Neck Surgery, and a member of several additional
editorial boards.

Dr. Brat’s clinical expertise is in Surgical Neuropathology. He has authored two textbooks in Surgical Neuropathology and is a lead editor for the World Health Organization (WHO) Classification of Brain Tumors. Among achievements that he is most proud include original descriptions of chordoid glioma and extra-ventricular neurocytoma, as well as foundational investigations of pituicytoma, astroblastoma and melanocytic neoplasms of the CNS. His work with The Cancer Genome Atlas (TCGA) on diffuse gliomas ushered in a new molecular classification that is incorporated into WHO diagnoses and the subject of College of American Pathology (CAP) clinical practice guidelines. He continues to work closely with international leaders to optimize and integrate molecular diagnostic features into classification and grading criteria for these tumors. He has trained over a 120 residents and fellows in Surgical Neuropathology and participated in over 75 CME courses nationally and internationally. Dr. Brat also directs a basic and translational research lab that investigates mechanisms of glioma progression, including contributions from genetics and the tumor microenvironment. In the laboratory setting, he has trained and mentored over 70 students, residents and fellows and was awarded Mentor of the Year for post-doctoral training. He has written more than 350 peer-reviewed manuscripts and reviews.

Dr. Brat has served in leadership positions that oversee clinical practice, education and investigation in Oncology and Pathology, including the TCGA; CAP Neuropathology Committee (Chair) and Council on Scientific Affairs; Education Committee of the USCAP; the President and Executive Council, American Association of Neuropathologists; Board of Directors, Society of Neuro-oncology; and American Joint Commission on Cancer (AJCC) CNS Expert Panel (Chair). He is a member of the American Society for Clinical Investigation and the Association of American Physicians and serves as the Deputy Editor for the Journal of Clinical Investigation (JCI).

A native of Oregon, Dr. Chadburn graduated from Stanford Medical School, and did her pathology residency at the now New York Presbyterian Hospital – Weill Cornell Medicine (NYP-WC) with a hematopathology fellowship at Columbia Presbyterian. She subsequently was part of the hematopathology faculties at Columbia Presbyterian, Northwestern-Feinberg School of Medicine and Weill Cornell Medicine, focusing her career on lymphoid lesions, particularly those arising in the setting of immunosuppression. She has had many leadership roles in these institutions including Director of the Immunopathology Laboratory, Interim Co-director of Surgical Pathology, Program Director of the Residency and Hematopathology Fellowship programs, Director of the Immunohistochemistry Laboratory and Vice Chair of Quality and Clinical Services. She established her departmental mentoring program and has been an active member of the General Faculty Council.

Dr. Chadburn has been a member of USCAP since residency with many roles in the organization including as a member on the abstract review committee, chairman of the Stowell-Orbison Award Committee, member of the education committee and a USCAP mentor. She has given courses at the annual meeting and in Palm Springs and has organized the Hematopathology night sessions. She is currently on SULCO. She has been active in the Society of Hematopathology (membership and executive committees), American Society of Clinical Pathology (education committee and co-chair of the annual meeting) and the New York Pathological Society (president). She is on the Oregon State University College of Science Advisory Board and meets with undergraduates to foster their interest in medicine and is on the Castleman Disease Collaborative Network (CDCN) Scientific Advisory Board. She performs central review for Alliance and AIDS Malignancy Consortium clinical trials (lymphoma) and for CDCN (Castleman cases).

She has over 200 peer reviewed papers and several book chapters and has written for the WHO Classification of Tumours (hematopathology) in 2008, 2016, 2022 and (digestive tract) 2019. She is on editorial boards including Modern Pathology and Archives of Pathology and Laboratory Medicine. She received the Arthur Purdy Stout award. She has been listed as a Castle Connolly Top Doctor in New York City and Chicago and a Castle Connolly Exceptional Woman in Medicine.

Dr. Faquin, who grew up in NC, now lives in Boston where he is Professor of Pathology at Harvard Medical School, Chief of Otolaryngologic Pathology at the Massachusetts Eye and Ear, Director of the MEE Frozen Section Laboratory, and a subspecialist in Head and Neck Pathology & Cytopathology at the Massachusetts General Hospital. He received his MD in 1993 from Harvard Medical School and obtained his PhD from Harvard studying erythrocyte cytoskeleton biochemistry. Dr. Faquin did his residency in Anatomic Pathology at the Brigham and Women’s Hospital in Boston (1993-1997) where he also completed fellowships in Women’s and Perinatal Pathology and Cytopathology. He joined the pathology faculty at the Massachusetts General Hospital in 1998. Dr. Faquin has been a member of USCAP for almost 30 years and an active contributor as co-director of multiple Head and Neck short courses & Interactive Microscopy courses at USCAP annual meetings, moderator of platform sessions, speaker at companion and evening specialty sessions, invited speaker at Interactive Microscopy courses at the Palm Springs Center, and faculty member in multiple USCAP Diagnostic Cytology Courses in the USA and abroad. Dr. Faquin has served on the USCAP Education Committee, Abstract Research Award Committee, DEI subcommittee, SULCO subcommittee, USCAP Mentoring Academy, and Chair of the Castleman Award Committee. He has also delivered numerous lectures at national and international meetings of the ASC, CAP, ECC, IAP, and ASCP, and served on the ASC Executive Board.

Dr. Faquin is recognized for his contributions to the study of thyroid, salivary gland, and HPV-related cancers of the head and neck. He has over 400 publications, and co-authored several books on head and neck cytohistology, salivary gland, and thyroid cytopathology. Dr. Faquin has been an Editorial Board member for 9 pathology journals, and is currently the Editor-in-Chief for Cancer Cytopathology. He is an author of the upcoming ARP Fascicle for Upper Aerodigestive Tract Tumors, co-author of the Bethesda System for Reporting Thyroid Cytopathology, co-chair of the CAP Guideline Committee for HPV testing in the head and neck, contributor to the 5th Edition of the WHO Classification of Head and Neck Tumours, and co-editor of the Milan System for Reporting Salivary Gland Cytopathology. In his free time, Dr. Faquin is an avid gardener and has been a bonsai artist for 53 years with a collection of over 60 bonsai pine trees.

Dr. Graham, originally from Barbados, is a Professor of Laboratory Medicine and Pathology at the Mayo Clinic in Rochester Minnesota. He received his medical degree from the University of the West Indies in Jamaica in 2006 before completing residency and fellowships, at Mayo Clinic, in Molecular Genetic Pathology, Surgical Pathology and GI/Liver Pathology. At the Clinic, Dr. Graham serves as the Executive Vice Chair of Academics and People in the Division of Anatomic Pathology, as well as the Associate Vice Chair of Test Development and the Lead Consultant for Business Development in the Department of Lab Medicine and Pathology. He is a member of the institution’s Academic Appointments and Promotions Committee and the Mayo Clinic Cancer Center Hepatobiliary Disease Group Executive Team. Dr. Graham is an academic GI/Liver pathologist whose scholarly interests are at the intersection of GI/Liver pathology and molecular genetics. He has authored over 195 peer-reviewed publications along with 27 book chapters and has been a contributor to the WHO Classification of Tumors of the Digestive System and the WHO Classification of Pediatric Tumors. He serves on the Editorial Board of Modern Pathology, is an Associate Editor for Journal of Molecular Diagnostics and reviews for over 2 dozen biomedical journals. He has been invited to give over 100 presentations at academic meetings and visiting professorships at national and international venues. In 2023, he was awarded the Arthur Purdy Stout Society Pathology Annual Prize Dr. Graham has served the USCAP in several administrative capacities including Abstract Review Committee, Lead Reviewer for the Liver Section, Focus Group on Diversity Equity and Inclusion (2018), the USCAP Membership Committee (2018-2021), Foundation Committee (current) and the CME Subcommittee (current) as well as educational roles such as moderator and course director. Dr. Graham lives in Rochester, Minnesota with his wife and 3 children. He is an avid soccer fan and loves growing orchids.

Dr. Hui is Professor in the Department of Pathology at Yale School of Medicine. He obtained his medical degree from Xi’an Jiaotong University in China in 1984 and PhD from SUNY at Buffalo in 1994. He received combined anatomic and clinical pathology residency training at Yale-New Haven Hospital in 2000, followed by oncological pathology fellowship training at MSKCC in 2001. Dr. Hui is a board-certified surgical pathologist with clinical expertise in gynecologic pathology and molecular genetic pathology. He is Director of Gynecologic Pathology, Clinical Director of Molecular Diagnostics Laboratory, and Director of Center for the Precision Medicine of Trophoblastic Disease at Yale School of Medicine. He has authored over 280 publications and four gynecological pathology textbooks. Dr. Hui serves on editorial boards of International Journal of Gynecological Pathology, Modern Pathology, Human Pathology and Virchows Archiv. Dr. Hui has played a significant role as a consensus/expert editorial board member for the 4th, 5th, and the ongoing 6th editions of the WHO Tumor Classifications of Female Reproductive Organs. He serves on the Board of Directors of the International Society of Gynecological Pathologists (ISGyP) and is currently the President-Elect of the society, reflecting his leadership and expertise in the field of gynecological pathology.

Dr. Hui has dedicated many years to serving the United States and Canadian Academy of Pathology (USCAP) in various capacities. His roles have included being a USCAP ambassador, abstract reviewer, and faculty member for USCAP specialty courses in 2012. He was course director of USCAP short courses in 2013, 2014, 2015, and more recently in 2022 and 2023. At the USCAP Interactive Center in Palm Springs, he contributed as faculty for the interactive microscopy course on intraoperative consultation in 2019 and served as program director for multiple interactive microscopy courses on gynecological pathology in 2017, 2018, and 2019. He also led co-branded interactive microscopy courses in collaboration with the International Society of Gynecological Pathologists (ISGyP) in 2021, 2022, and 2024. Dr. Hui’s unwavering commitment to the Academy’s mission is evident in his efforts to foster academic collaborations, drive innovations, and enhance the clinical practice of pathology with a global impact.

Nicole C. Panarelli, MD, is Chief of GI and Liver Pathology and Vice Chair for Education and Faculty Development at Weill Cornell Medicine in New York, NY. Dr. Panarelli completed her residency in anatomic pathology at NewYork-Presbyterian Hospital, Weill Cornell Medicine followed by fellowship in gastrointestinal and liver pathology at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. Her work on the pathology of digestive disorders has been published in numerous peer-reviewed journals, articles, books and chapters, and she has presented nationally and internationally. Dr. Panarelli is an Associate Editor for Modern Pathology and is a Section Editor for Archives of Pathology and Laboratory Medicine. She is Past-President of the Rodger C. Haggitt Gastrointestinal Pathology Society and Treasurer of the Arthur Purdy Stout Society of Surgical Pathologists. She is also a member of the Education Committee of the United States and Canadian Academy of Pathology.

Dr. Westerhoff is a full professor and the Assistant Chair of Wellness and Culture at the University of Michigan. Originally from Seoul, South Korea, she completed her residency and gastrointestinal and liver fellowship at the University of Chicago. She began her academic career at the University of Washington in 2011, where she was recognized twice as Faculty Educator of the Year. She has been a member of the University of Michigan Pathology Department since 2017. Dr. Westerhoff has attended every USCAP meeting since her first year of residency. She served as Lead Reviewer of the Liver Pathology Category as part of the USCAP Abstract Review Committee. She was also a member of the USCAP Publications Committee and was elected to the USCAP Education Committee in 2019. Dr. Westerhoff has presented in multiple USCAP offerings, including at the USCAP Evening Specialty conferences for both Gastrointestinal and Liver subspecialties. She has also taught USCAP Liver Pathology Short Courses alongside Drs. John Hart and Lei Zhao. In addition, Dr. Westerhoff has participated as a faculty member of multiple USCAP Interactive Microscopy Courses. Dr. Westerhoff has experience serving on the executive boards of multiple companion societies. She is the Past-President of the Rodger Haggitt GI Pathology Society (GIPS) and has previously organized the content and speakers for the 2019 USCAP Companion Society meeting for GIPS. Moreover, she has also organized GIPS symposia at ASCP, CAP, European Congress of Pathology, and Digestive Disease Week. She served as Treasurer of the Arthur Purdy Stout Society of Surgical Pathologists from 2019-2023. She is a member of the Korean Pathologists Association of North America, the Laennec Liver Society, and has participated as a Journal Club writer for the Hans Popper Hepatopathology Society. Dr. Westerhoff has given numerous lectures nationally and internationally to multidisciplinary audiences regarding both liver and gastrointestinal topics. She has authored over 100 peer reviewed publications, the Hepatobiliary and Pancreas textbook of the Elsevier Diagnostic Pathology series, and 17 book chapters. She lives in Ann Arbor, Michigan, with her husband and three children. She enjoys promoting wellness in her department for faculty, staff, and trainees.